SHOGAT Prof Dimitar Stamatov
About SHOGAT Prof Dimitar Stamatov
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
4
Clinical Trials at SHOGAT Prof Dimitar Stamatov
During the past decade, SHOGAT Prof Dimitar Stamatov conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
2017-07-31
2021-10-25
Completed
766
Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy
2019-09-25
2021-02-12
Completed
113
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb
2021-01-29
2022-05-03
Completed
194
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause
2021-08-27
2024-01-26
Active, not recruiting
628
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "SHOGAT Prof Dimitar Stamatov"
#1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at SHOGAT Prof Dimitar Stamatov
According to Clinical.Site data, the most researched conditions in "SHOGAT Prof Dimitar Stamatov" are
"Endometriosis" (1 trials), "Hot Flashes" (1 trials), "Retinopathy of Prematurity (ROP)" (1 trials), "Uterine Fibroids" (1 trials) and "Vasomotor Symptoms Associated With Menopause" (1 trials). Many other conditions were trialed in "SHOGAT Prof Dimitar Stamatov" in a lesser frequency.
Clinical Trials Intervention Types at SHOGAT Prof Dimitar Stamatov
Most popular intervention types in "SHOGAT Prof Dimitar Stamatov" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "BAY1817080" (1 trials), "Elagolix" (1 trials), "Elinzanetant (BAY3427080)" (1 trials) and "Eylea (Aflibercept, BAY86-5321)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SHOGAT Prof Dimitar Stamatov
The vast majority of trials in "SHOGAT Prof Dimitar Stamatov" are
3 trials for "Female" genders and 1 trials for "All" genders.
Clinical Trials Status at SHOGAT Prof Dimitar Stamatov
Currently, there are NaN active trials in "SHOGAT Prof Dimitar Stamatov".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in SHOGAT Prof Dimitar Stamatov,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SHOGAT Prof Dimitar Stamatov, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".